Can you explain the pathophysiology, clinical presentation, diagnosis, and management of paralytic ileus?

Paralytic Ileus: Comprehensive Overview

Paralytic ileus is an impairment of bowel motor activity without mechanical obstruction that, if prolonged and untreated, can be life-threatening 1.

Pathophysiology

The underlying mechanisms are multifactorial, involving neurohormonal dysfunction, gastrointestinal inflammation, fluid overload, and exogenous opioid effects 2. The condition results from a complex inflammatory cascade within the bowel wall:

• Inflammatory mechanisms: Surgical trauma triggers recruitment of immune cells (macrophages, dendritic cells, T lymphocytes) to manipulation sites, initiating inflammatory events that directly impair gut motility 3
• Sympathetic hyperreactivity: Excessive sympathetic nervous system activation inhibits coordinated bowel activity 4
• Opioid effects: Exogenous opioids directly suppress gastrointestinal motility 2
• Fluid overload: Excessive salt and water administration contributes to intestinal edema and dysfunction 5, 2
• Gastrointestinal stretch: Physical distension from accumulated gas and secretions perpetuates the cycle 2

The duration correlates with surgical trauma degree, being most extensive after colonic surgery, though it can develop after any surgery including extraperitoneal procedures 6.

Clinical Presentation

Patients experience:

• Accumulation of secretions and gas
• Nausea and vomiting
• Abdominal distension
• Abdominal pain
• Absence of coordinated bowel activity

Postoperative ileus lasting more than 3 days after surgery is considered prolonged and pathological 6. In the postoperative context, POI is one of the most frequent complications and the single largest factor influencing hospital length of stay after bowel resection 5, 1.

Diagnosis

The diagnosis relies on clinical assessment of:

• Time to first flatus
• Time to first bowel movement
• Tolerance of oral intake
• Presence/absence of bowel sounds (though this is less reliable)
• Abdominal distension and discomfort

Look specifically for risk factors: right colon surgery (OR 2.180), preoperative chemotherapy (OR 2.530), preoperative antithrombotic drugs (OR 2.210), and severe postoperative complications (Clavien-Dindo grade ≥3, OR 12.90) 7.

Management

Prevention (Primary Strategy)

A multifaceted prevention approach is essential and strongly recommended 5. The key components, listed in order of evidence strength:

Pharmacological Prevention:

1. Opioid-sparing analgesia: Use thoracic epidural with local anesthetic when possible 5, 2, 6

   • Perioperative intravenous Lidocaine reduces time to first defecation by 5.97 hours and shortens hospitalization by 0.67 days 4
   • Dexmedetomidine reduces time to first defecation by 13 hours and hospitalization by 1.28 days 4
   • Nonopioid analgesics reduce hospitalization by 1.29 days 4

2. Peripheral opioid antagonism: Alvimopan (oral, perioperative) reduces time to GI-2 recovery by 15.33 hours and hospitalization by 0.58 days 4

3. Early laxatives: Bisacodyl and magnesium oxide should be administered early 5, though evidence shows efficacy for bowel movements but not food tolerance or hospitalization 4

Non-Pharmacological Prevention:

1. Optimized fluid management: Critical to balance adequate resuscitation while avoiding overload

   • Target weight gain <3 kg by postoperative day 3 5
   • Correct fluid status early 5

2. Minimally invasive surgery: Reduces surgical trauma and inflammatory response 5

3. Early mobilization: Begin as soon as medically feasible 5

4. Early postoperative feeding:

   • Encourage oral intake within 24 hours when possible 5
   • For patients with ileus or intestinal edema, offer small portions initially, especially after right-sided resections 5
   • If oral intake inadequate (<50% caloric requirement for >7 days), initiate tube feeding within 24 hours 5

5. Nasogastric tube management: Omit or remove early 5, 2

Important caveat: Enteral feeding is contraindicated in intestinal obstruction, ileus, sepsis, intestinal ischemia, high-output fistulae, and severe GI hemorrhage—in these cases, use early parenteral nutrition 5.

Treatment of Established POI

Evidence for treating clinically evident POI is limited 4. Available options:

• Neostigmine: Single study shows reduction in time to flatus by 37 hours and bowel movements by 43 hours, though evidence quality is low 4
• Water-soluble contrast agents: Some evidence supports use 5
• Continue supportive measures: fluid optimization, minimize opioids, early mobilization

Chewing gum is NOT recommended—current evidence does not support its use in ERAS pathways 5.

Common Pitfalls to Avoid:

• Fluid overload masquerading as adequate resuscitation
• Continued opioid use when alternatives exist
• Delayed recognition in high-risk patients (right colon surgery, preoperative chemotherapy)
• Premature aggressive enteral feeding in patients with contraindications
• Prolonged nasogastric decompression without indication